NYSE:GSK - GlaxoSmithKline News Headlines

$40.38
-0.25 (-0.62 %)
(As of 06/26/2019 02:50 PM ET)
Today's Range
$40.17
Now: $40.38
$40.43
50-Day Range
$38.64
MA: $39.71
$40.7369
52-Week Range
$36.41
Now: $40.38
$42.32
Volume73,141 shs
Average Volume2.34 million shs
Market Capitalization$100.17 billion
P/E Ratio12.78
Dividend Yield4.81%
Beta0.74

Headlines

GlaxoSmithKline (NYSE GSK) News Headlines

Source:
DateHeadline
Asia-Pacific Over the Counter (OTC) Drugs Market Report 2019-2024 with Key Player Profiles on Johnson & Johnson, Novartis, Bayer, GlaxoSmithKline, and Pfizer - ResearchAndMarkets.com - Yahoo FinanceAsia-Pacific Over the Counter (OTC) Drugs Market Report 2019-2024 with Key Player Profiles on Johnson & Johnson, Novartis, Bayer, GlaxoSmithKline, and Pfizer - ResearchAndMarkets.com - Yahoo Finance
finance.yahoo.com - June 25 at 5:54 PM
2018 Market Spotlight: Benign Prostatic Hyperplasia (BPH) - GlaxoSmithKline Leads Industry Sponsors with the Highest Number of Overall Clinical Trials for BPH, Followed by Astellas & Sanofi - ResearchAndMarkets.com - Yahoo Finance2018 Market Spotlight: Benign Prostatic Hyperplasia (BPH) - GlaxoSmithKline Leads Industry Sponsors with the Highest Number of Overall Clinical Trials for BPH, Followed by Astellas & Sanofi - ResearchAndMarkets.com - Yahoo Finance
finance.yahoo.com - June 20 at 10:19 PM
Glaxo offers concessions to address Pfizer deal concerns - Seeking AlphaGlaxo offers concessions to address Pfizer deal concerns - Seeking Alpha
seekingalpha.com - June 20 at 9:52 AM
AstraZeneca's Triple-Combo COPD Inhaler Gets Japan's NodAstraZeneca's Triple-Combo COPD Inhaler Gets Japan's Nod
finance.yahoo.com - June 20 at 9:52 AM
GlaxoSmithKline selling consumer portfolios, raising $1.3B - Seeking AlphaGlaxoSmithKline selling consumer portfolios, raising $1.3B - Seeking Alpha
seekingalpha.com - June 19 at 5:54 PM
Health Care Digest: Not-so-secret target of new UC-GSK alliance, East Bay toolmaker's big round and moreHealth Care Digest: Not-so-secret target of new UC-GSK alliance, East Bay toolmaker's big round and more
finance.yahoo.com - June 17 at 10:53 AM
GlaxoSmithKline (NYSE:GSK) Coverage Initiated by Analysts at Morgan StanleyGlaxoSmithKline (NYSE:GSK) Coverage Initiated by Analysts at Morgan Stanley
www.americanbankingnews.com - June 17 at 8:29 AM
Here’s What Hedge Funds Think About GlaxoSmithKline plc (GSK) - Yahoo FinanceHere’s What Hedge Funds Think About GlaxoSmithKline plc (GSK) - Yahoo Finance
finance.yahoo.com - June 14 at 5:20 PM
Here’s What Hedge Funds Think About GlaxoSmithKline plc  (GSK)Here’s What Hedge Funds Think About GlaxoSmithKline plc (GSK)
finance.yahoo.com - June 14 at 5:20 PM
GlaxoSmithKline plc (NYSE:GSK) Receives Consensus Rating of "Hold" from AnalystsGlaxoSmithKline plc (NYSE:GSK) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - June 14 at 4:28 PM
Amgen, Biogen, Gilead and Novo Nordisk have ‘very high’ capacity for M&A, says Moody’sAmgen, Biogen, Gilead and Novo Nordisk have ‘very high’ capacity for M&A, says Moody’s
finance.yahoo.com - June 13 at 5:57 PM
GlaxoSmithKline, UC team up to turn CRISPR toward drugs - San Francisco Business Times - San Francisco Business TimesGlaxoSmithKline, UC team up to turn CRISPR toward drugs - San Francisco Business Times - San Francisco Business Times
www.bizjournals.com - June 13 at 10:17 AM
Edited Transcript of GSK.L earnings conference call or presentation 25-Oct-17 1:00pm GMTEdited Transcript of GSK.L earnings conference call or presentation 25-Oct-17 1:00pm GMT
finance.yahoo.com - June 13 at 10:17 AM
GSK links up with US university on genome researchGSK links up with US university on genome research
finance.yahoo.com - June 13 at 10:17 AM
GlaxoSmithKline (NYSE:GSK) Receives Hold Rating from CowenGlaxoSmithKline (NYSE:GSK) Receives Hold Rating from Cowen
www.americanbankingnews.com - June 10 at 8:47 AM
Global External Nasal Dilator Market to 2023 with Market Positioning of Major Vendors - GlaxoSmithKline, HealthRight Products, & Walmart - GlobeNewswireGlobal External Nasal Dilator Market to 2023 with Market Positioning of Major Vendors - GlaxoSmithKline, HealthRight Products, & Walmart - GlobeNewswire
globenewswire.com - June 7 at 8:00 AM
STADA to buy six Glaxo consumer brands - Seeking AlphaSTADA to buy six Glaxo consumer brands - Seeking Alpha
seekingalpha.com - June 7 at 8:00 AM
Germany's Stada buys six of GSK's consumer brands, eyes further dealsGermany's Stada buys six of GSK's consumer brands, eyes further deals
finance.yahoo.com - June 7 at 8:00 AM
Better Buy: GlaxoSmithKline vs. Merck - Yahoo FinanceBetter Buy: GlaxoSmithKline vs. Merck - Yahoo Finance
finance.yahoo.com - June 6 at 10:22 AM
Glaxo's Nucala Gets CHMP Nod for 2 Self-Administered OptionsGlaxo's Nucala Gets CHMP Nod for 2 Self-Administered Options
finance.yahoo.com - June 5 at 10:03 AM
Emergent (EBS) Wins HHS Contract to Supply VIGIV ProductEmergent (EBS) Wins HHS Contract to Supply VIGIV Product
finance.yahoo.com - June 4 at 5:22 PM
Trump strikes "supportive" tone in meeting with British business leaders -sourcesTrump strikes "supportive" tone in meeting with British business leaders -sources
finance.yahoo.com - June 4 at 10:12 AM
Gilead Gains 6.8% YTD as HIV Franchise Maintains MomentumGilead Gains 6.8% YTD as HIV Franchise Maintains Momentum
finance.yahoo.com - May 28 at 5:26 PM
Glaxo's Shingles Vaccine Shingrix Gets Approval in ChinaGlaxo's Shingles Vaccine Shingrix Gets Approval in China
finance.yahoo.com - May 27 at 9:09 AM
GlaxoSmithKline revamps incentives for sales representatives - Financial TimesGlaxoSmithKline revamps incentives for sales representatives - Financial Times
www.ft.com - May 23 at 5:48 PM
3 Top Stocks With High Dividend Yields - Motley Fool3 Top Stocks With High Dividend Yields - Motley Fool
www.fool.com - May 23 at 10:08 AM
Better Buy: Johnson & Johnson vs. GlaxoSmithKline - Motley FoolBetter Buy: Johnson & Johnson vs. GlaxoSmithKline - Motley Fool
www.fool.com - May 23 at 10:08 AM
GlaxoSmithKline Breaks Above 200-Day Moving Average - Bullish for GSKGlaxoSmithKline Breaks Above 200-Day Moving Average - Bullish for GSK
www.nasdaq.com - May 22 at 5:41 PM
GlaxoSmithKlines Jack Bailey on value-based care experiments - Business InsiderGlaxoSmithKline's Jack Bailey on value-based care experiments - Business Insider
www.businessinsider.com - May 21 at 5:21 PM
Merck's Keytruda Fails in Late-Stage Breast Cancer StudyMerck's Keytruda Fails in Late-Stage Breast Cancer Study
finance.yahoo.com - May 21 at 12:10 PM
Why I’d snap up this FTSE 100 pharmaceutical provider alongside GlaxoSmithKline - Yahoo Finance UKWhy I’d snap up this FTSE 100 pharmaceutical provider alongside GlaxoSmithKline - Yahoo Finance UK
uk.finance.yahoo.com - May 17 at 5:29 PM
Thermo Fisher Acquires GlaxoSmithKline's Drug Production SiteThermo Fisher Acquires GlaxoSmithKline's Drug Production Site
finance.yahoo.com - May 17 at 10:00 AM
How to Invest in Biotech: Known Your CatalystsHow to Invest in Biotech: Known Your Catalysts
finance.yahoo.com - May 16 at 5:36 PM
GSK expands collaboration with ZymeworksGSK expands collaboration with Zymeworks
seekingalpha.com - May 16 at 7:50 AM
Thermo Fisher Scientific to Acquire Manufacturing Site in Cork, Ireland, from GSKThermo Fisher Scientific to Acquire Manufacturing Site in Cork, Ireland, from GSK
finance.yahoo.com - May 16 at 7:49 AM
Global Staphylococcal Infection Drugs Market to 2023 with Allergan, Bayer, GlaxoSmithKline, Merck & Co. and Pfizer Dominating - GlobeNewswireGlobal Staphylococcal Infection Drugs Market to 2023 with Allergan, Bayer, GlaxoSmithKline, Merck & Co. and Pfizer Dominating - GlobeNewswire
www.globenewswire.com - May 13 at 9:27 AM
Top vaccine makers Merck and Pfizer target China and older adults next - CNBCTop vaccine makers Merck and Pfizer target China and older adults next - CNBC
www.cnbc.com - May 12 at 4:59 PM
Clovis (CLVS) Q1 Earnings Top Estimates, Rubraca Sales StrongClovis (CLVS) Q1 Earnings Top Estimates, Rubraca Sales Strong
finance.yahoo.com - May 8 at 5:38 PM
Theravance (TBPH) Q1 Loss Widens, Revenues Miss EstimatesTheravance (TBPH) Q1 Loss Widens, Revenues Miss Estimates
finance.yahoo.com - May 8 at 5:38 PM
Comparing the Revenue Growth Trajectories of PFE and GSKComparing the Revenue Growth Trajectories of PFE and GSK
finance.yahoo.com - May 7 at 5:35 PM
What's in Store for Axsome (AXSM) This Earnings Season?What's in Store for Axsome (AXSM) This Earnings Season?
finance.yahoo.com - May 7 at 5:35 PM
UKs Vectura wins patent infringement case against GlaxoSmithKline in U.S - ReutersUK's Vectura wins patent infringement case against GlaxoSmithKline in U.S - Reuters
www.reuters.com - May 4 at 5:12 PM
Investors Chronicle: Greene King, Standard Chartered, GlaxoSmithKline - Financial TimesInvestors Chronicle: Greene King, Standard Chartered, GlaxoSmithKline - Financial Times
www.ft.com - May 3 at 5:38 PM
Emergent (EBS) Earnings & Revenues Miss Estimates in Q1Emergent (EBS) Earnings & Revenues Miss Estimates in Q1
finance.yahoo.com - May 3 at 5:38 PM
GlaxoSmithKline plc (GSK) Q1 2019 Earnings Call Transcript - Motley FoolGlaxoSmithKline plc (GSK) Q1 2019 Earnings Call Transcript - Motley Fool
www.fool.com - May 3 at 10:20 AM
Is GlaxoSmithKline a Buy? - Motley FoolIs GlaxoSmithKline a Buy? - Motley Fool
www.fool.com - May 3 at 10:20 AM
Glaxos Trelegy Ellipta successful in late-stage asthma study - Seeking AlphaGlaxo's Trelegy Ellipta successful in late-stage asthma study - Seeking Alpha
seekingalpha.com - May 2 at 5:40 PM
Is GlaxoSmithKline a Buy? - Yahoo FinanceIs GlaxoSmithKline a Buy? - Yahoo Finance
finance.yahoo.com - May 2 at 5:40 PM
GSKs Trelegy Ellipta meets key goal in late-stage asthma studyGSK's Trelegy Ellipta meets key goal in late-stage asthma study
finance.yahoo.com - May 2 at 5:40 PM
GSKs 3-in-1 inhalable drug shows promise in asthma studyGSK's 3-in-1 inhalable drug shows promise in asthma study
finance.yahoo.com - May 2 at 5:40 PM
This page was last updated on 6/26/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel